ETFs DBV Technologies

DBV

FR0010417345

Pharmaceuticals

Real-time Euronext Paris 09:57:44 2026-09-16 EDT			5-day change	1st Jan Change
2.104 ^EUR	+1.64%		-10.77%	-37.75%

09-15	European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading	MT
09-14	European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading	MT

ETFs positioned on DBV Technologies

Name	YTD change	Weight	AuM
STATE STREET SPDR S&P INTERNATIONAL SMALL CAP ETF - USD	+12.89%	0.01%	918 M€
STATE STREET SPDR PORTFOLIO EUROPE ETF - USD	+6.00%	0%	742 M€
STATE STREET SPDR GLOBAL ALLOCATION ETF - DISTRIBUTING - USD	+7.44%	0%	317 M€
WARREN STREET GLOBAL EQUITY ETF - USD	+13.01%	0%	62 M€

DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.

Employees

170

Sector

Pharmaceuticals

Calendar

10-27 Earnings release - Q3 2026

More about the company